Angiopoietins (Angs) are important angiogenic and endothelial cell growth factors with many functions, including influence on the vascular wall. Pulse-wave velocity (pwv) is an independent marker of cardiovascular adverse outcome in hypertensives, although all the pathophysiological mechanisms that affect it have not yet been determined. We investigated the relationship between arterial stiffness and Ang-1 and Ang-2 gene expression in the peripheral blood monocytes of hypertensive patients. We studied 53 patients who had untreated grade-1 or grade-2 essential hypertension and no indications of other organic heart disease. Carotid-femoral (c-f) and carotid-radial (c-r) artery waveforms were measured and pwv was determined. The monocytes were isolated using anti-CD14 þ antibodies and mRNAs were estimated by real-time quantitative reverse transcription-PCR. Ang-1 gene expression was strongly correlated with both c-f-pwv (r ¼ 0.952, Po0.001) and c-r-pwv (r ¼ 0.898, Po0.001). Similarly, Ang-2 gene expression was significantly correlated with both c-f-pwv (r ¼ 0.471, P ¼ 0.002) and c-r-pwv (r ¼ 0.437, P ¼ 0.003). Our data provide important evidence that Ang-1 and Ang-2 gene expression levels in peripheral monocytes are closely related with pwv in patients with essential hypertension. This positive correlation may suggest a link between angiogenesis and arterial stiffness in those patients.
Introduction
Arterial hypertension is undoubtedly related to increased cardiovascular mortality and morbidity. Over the past several years, large arterial stiffness has become prominent as an important independent predictor of cardiovascular mortality in hypertensive patients, and changes in arterial properties have been proved to have an impact on cardiovascular risk in hypertensives. 1, 2 Pulse-wave velocity (pwv) is a useful index for evaluating arterial stiffness and is an independent predictor of mortality in patients with hypertension. 2 Although reduction in blood pressure (BP) can reduce the pwv, these changes are not always proportional, 3 suggesting that, apart from BP levels, there are other pathophysiological mechanisms that affect arterial stiffness.
On the other hand, pathological angiogenesis is also an important feature of hypertension. Recently, there has been enormous interest in angiogenic growth factors in cardiovascular diseases, since these factors play very specific and crucial roles in the vasculature. Arterial hypertension is associated with altered angiogenesis and increased levels of various angiogenic markers. 4 In particular, hypertensive patients exhibit higher levels of plasma angiopoietin-1 (Ang-1) and Ang-2, 5 which are correlated with target organ damage 6 and cardiovascular outcome. 4, 7, 8 Although Angs may exert a potent mitogenic effect and promote arterial remodelling, 9 the underlying pathophysiological mechanisms potentially linking angiogenesis with adverse outcome in hypertension are largely unclear.
In this study, we investigated a potential association between arterial stiffening and Ang-1 and Ang-2 gene expression in peripheral monocytes in patients with essential hypertension. We used pwv for the evaluation of arterial stiffness. Pwv is not the only measure of arterial stiffness, nor is it adequate for characterizing the pathophysiology of arterial 'stiffening'; however, it is now widely accepted as the 'gold standard' measure for this purpose. 10 We also focused on peripheral blood monocytes, since arterial hypertension is accompanied by functional changes in monocytes and these cells are the main participants in hypertension-related atherogenesis.
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Materials and methods
Study population
The study population was recruited from the cardiology outpatients' department and consisted of individuals who had untreated grade-1 or grade-2 essential hypertension, with no indications of other organic heart disease. The diagnosis of hypertension was based on three outpatient measures of BP greater than 140/90 mm Hg at intervals no longer than 2 weeks, according to the recommendations of the European Society of Hypertension/European Society of Cardiology. 12 Participants with BP 4140/90 mm Hg on the final visit underwent 24-h ambulatory BP monitoring. To be eligible for inclusion in the study, a mean 24-h BP 4130/80 mm Hg was required.
Patients, whose age ranged from 50 to 75 years, had not previously taken any hypertensive medication and did not take any other drugs for 3 weeks before the studies. The following were the criteria for exclusion: heavy smokers; pregnant or lactating women; previous history or medication for hypertension; patients with grade-3 hypertension or secondary hypertension; tachy-or bradyarrythmias; coronary artery disease; cerebrovascular, liver or renal disease (glomerular filtration rate o60 ml/min/1.73 m 2 ); albumin excretion rate 4200 mg min
À1
; history of drug or alcohol abuse; any chronic inflammatory or other infectious disease during the last 6 months; thyroid gland disease; and body mass index 425 kg m
À2
. In addition, vascular, metabolic or neoplastic conditions were ruled out by careful examination of the history and routine laboratory tests.
All subjects were asked to refrain from caffeine, alcohol and smoking during the preceding 12 h. The study was conducted between 0800 and 0900 hours in a quiet room at 22±1 1C. Height and weight were measured. Subjects were allowed a further 15-min supine rest before baseline measurements. Brachial BP was measured over the brachial artery three times at 5-min intervals. The mean of the last two measurements was recorded as representative of brachial BP. After brachial BP, the carotid, femoral and radial arteries were palpated to find the location of the points with the most pronounced pulse pressure waves. Carotid-femoral (c-f) and carotidradial (c-r) artery waveforms were measured and pwv (Complior SP; Atech Medical, Pantin, France) was determined. The distance travelled by the pulse waves was assessed in triplicate over the surface of the body using a non-elastic tape measure. Pulse wave transit time was determined from the time delay between the proximal and distal ''foot'' waveforms.
All patients gave written informed consent. The Institutional Ethics Committee approved the study.
Blood collection and monocyte separation Twenty millilitres of blood were obtained from each patient. The blood was processed according to a procedure that has been described previously, 13 and mononuclear cells were isolated. A cell yield averaging 10 6 cells ml À1 of CD14 þ monocytes was purified from mononuclear cells by positive selection using MACS high-gradient magnetic separation column-type MS. Purity was assessed by fluorescence-activated cell sorting (FACSCalibur; Beckton Dickinson, San Jose, CA, USA) analysis was 495%.
RNA isolation and quantitative reverse transcription-PCR Total RNA was isolated from peripheral blood monocytes according to the Trizol reagent protocol (Invitrogen Corp., Carlsbad, CA, USA). Subsequently, mRNA was reverse-transcribed by using the Reverse Transcription System (Promega Corp., Madison, WI, USA). Measurements of mRNA levels were performed by real-time reverse transcription-PCR using the Mx3000P Detection System (Stratagene, La Jolla, CA, USA). GAPDH (glyceraldehyde-3-phosphate dehydrogenase) was used as the control housekeeping gene. The primers used were 5 0 -GACTGGGAAGGGAACCGAG-3 0 (sense) and (antisense) for GAPDH. Reactions were set in triplicates using the SYBR Green PCR Master Mix (Bio-Rad, Hercules, CA, USA) and the mean value of the triplicates was used to calculate mRNA expression levels. Amplification products were quantified by the standard curve method. The specificity of the amplification products was determined by performing a melting-curve analysis. Relative quantification of the signals was performed by normalizing with the GAPDH signal.
Statistical analysis
Data are summarized as mean (s.d.) or counts (%), as appropriate. Due to the right-skewed nature of the distributions of Ang-1 and Ang-2 gene expression, log10 transformations were performed and used in all subsequent analysis. Pearson correlation coefficients were computed between pwv and clinical parameters of interest. Stepwise linear regression analysis was used to determine which of the significantly related variables at the univariate level remained independently significant. The thresholds for entry into and removal from the model were 5 and 10%, respectively. A P-value o5% was the criterion for significance.
Results
The participants' demographic and biochemical data are presented in Table 1 . Our analysis revealed a positive correlation between the levels of Ang-1 and Ang-2 gene expression in peripheral monocytes and c-f and c-r-pwv ( Figure 1 ). More specifically, log10 (Ang-1) gene expression was strongly correlated with c-f-pwv (r ¼ 0.952, Po0.001) and with c-r-pwv (r ¼ 0.898, Po0.001). Log10 (Ang-2) gene expression was also significantly correlated, although less strongly, with both c-f-pwv (r ¼ Stepwise linear regression analysis showed that, among the variables that exhibited significant correlation at the univariate level, log10 (Ang-1) and left ventricular mass index remained independently associated with c-f-pwv and only log10 (Ang-1) remained independently associated with c-r-pwv.
Discussion
Our study provides data for the first time that demonstrate a correlation between the angiogenic mechanisms and the severity of arterial stiffness in hypertensive patients. Hypertension induces structural alterations in the arterial wall, increases the thickness of the wall, increases the wall-to-lumen ratio and alters the composition of the arteries. 14, 15 Complex interaction between the changes involves the structural and cellular elements of the vessel wall and is implicated in the pathophysiology of arterial stiffness. Changes in arterial properties have an impact on cardiovascular risk in hypertensives. Importantly, increased arterial stiffness is an independent factor for the development of atherosclerosis and an adverse cardiovascular outcome in essential hypertension, 2, [16] [17] [18] although the mechanisms involved have not been fully elucidated.
Angiopoietins play critical roles in the latter stages of angiogenesis; they contribute to the communication between endothelial cells and the surrounding mesenchyme through cellular and biochemical interactions. 19 Additionally, the Ang system, which is one of the most crucial regulators of the neovascularisation process, is involved in smooth-muscle-cell hyperplasia and blood vessel wall remodelling. 20 Expression of angiogenic growth factors is increased by the renin-angiotensin system, whose role predominates in essential hypertension. Infusion of angiotensin-II in animal models induced the expression of Ang-1 and Ang-2 mainly through AT2 receptors. 21 On the other hand, abnormal angiogenesis has been demonstrated in hypertension. 22, 23 Previous studies have demonstrated that hypertensive patients exhibit elevated plasma levels of Ang-1 and Ang-2. 5 Moreover, abnormal indices of angiogenesis in hypertension are correlated with target organ damage 6 and cardiovascular outcome. 4, 7, 8 The elevated Ang levels in hypertension suggest the possibility of alterations in the whole vessel remodelling process. 24 Given that angiogenesis plays a pivotal role in cardiovascular remodelling that may alter the mechanical wall properties, we sought a correlation between arterial stiffening, as expressed by pwv, and Ang-1 and Ang-2 gene expression in peripheral monocytes in patients with essential hypertension. To the best of our knowledge, this is the first study to investigate the relationship between arterial stiffness and the gene expression of angiogenic factors in peripheral monocytes. We found a strong positive correlation between Ang gene expression and pwv, which allows us to hypothesize that Ang levels in Abbreviations: c-f-pwv, carotid-femoral pulse-wave velocity; c-rpwv, carotid-radial pulse-wave velocity; DBP, diastolic blood pressure; HbA1c, glycated haemoglobin; MBP, mean blood pressure; SBP, systolic blood pressure.
the peripheral monocytes of hypertensive patients may be related to increased arterial stiffness via pathological angiogenesis. Although the exact link between Angs and pwv is unknown, there are some hypothetical mechanisms through which Ang could influence arterial stiffness at the cellular level. There is evidence suggesting that Ang-1 regulates pathological smooth-muscle-cell hyperplasia. 25 Additionally, previous researchers have demonstrated a profibrotic and inflammatory effect of Ang in a kidney disease model. 26 Ang1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. However, it cannot be said with certainty that increased Ang-1 and Ang-2 gene expression in peripheral monocytes leads to increase in pwv, since it is not clear whether Ang is the cause of the increase in pwv, or whether the latter is related with subclinical atherosclerosis that has escaped diagnosis. In addition, we cannot rule out the possibility that the increase in Angs could be compensatory and their action protective, since there are indications from some studies that they may reduce target organ damage in a hypertensive animal model. 27 A previous study by Sie et al. 28 was the first that attempted to find a relation between arterial stiffness and angiogenic factors, and more specifically transforming growth factor. The study was not able to show any significant correlation. However, the population and design of the study was completely different from ours; moreover, the authors did not examine the expression of the angiogenic factors per se, but rather evaluated polymorphisms used in the literature based on their potential functionality.
We evaluated Ang gene expression in peripheral monocytes. Circulating peripheral monocytes and their activation play an important role in the early stages of atherosclerotic lesion formation, which might be an important link between pathological arterial stiffness and atherogenesis. Also, peripheral monocytes have a crucial role in the cardiovascular complications of hypertensives, since hypertension induces the expression of adhesion molecules and cytokines, leads to increased monocyte adhesion to the vascular wall 29 and induces the migration of monocytes/macrophages into the vascular wall in target organs, 30 contributing to the development of atherosclerosis. Dorffel et al. 31 have shown that monocytes freshly isolated from the peripheral blood of hypertensive patients are characterized by markedly enhanced spontaneous and angiotensin-II-stimulated adhesion to endothelial cells in comparison with that in healthy participants. Arterial hypertension is accompanied by functional changes in monocytes that participate in hypertension-related atherogenesis. 11 We have shown that pwv, a significant marker of target organ damage in patients with essential hypertension, is related to expression of Ang-1 and Ang-2 in peripheral monocytes-a finding that strongly suggests the involvement of the latter cells in the pathophysiology of the complications of hypertension.
Limitations
One major limitation of our study was that we did not fully assess arterial stiffness using the central augmentation index. In order to obtain as accurate information as possible, we selected older patients (450 years), for whom it is known that aortic pwv is likely to be a better measure than the central augmentation index, 32 and is now widely accepted as the 'gold standard' measure for this purpose. 10 Magnetic antibody cell separation is regarded as a relatively simple, fast and reliable method for cell isolation. 33 However, the variation of this technique has not been studied and we cannot exclude the possibility that this might have had an influence on our results. Also, we do not know to what degree the medication of diabetics or the level of their diabetic control might have affected arterial stiffness.
We did not include a group of healthy individuals in our study. Instead, we focused on studying Ang levels in hypertensives. The lack of a control group did not allow us to evaluate whether the associations we found are specific for hypertension or reflect physiological or age-related relations. However, the evaluation of Ang gene expression levels in normotensives with increased pwv might be the aim of a future investigation.
In addition, we did not evaluate Angs at a posttranscriptional level, but examined only Ang gene expression in peripheral monocytes. Nevertheless, even this imperfect approach was sufficient to detect a significant relation between angiogenesis and arterial stiffness. In addition we could not exclude patients with tortuous arteries, which may lead to incorrect measurements of the distance of pulse wave. Finally, the small number of participants might have obscured other significant correlations and may limit its clinical significance.
Conclusion
In conclusion, our data provide important evidence that the levels of expression of the Ang-1 and Ang-2 genes in peripheral monocytes are closely related with pwv in patients with essential hypertension. These data reveal associations between pwv and Ang, but do not elucidate the cause-and-effect mechanisms. However, the positive correlation we found may suggest a link between angiogenesis and arterial stiffness in those patients. Future studies using larger series of patients are necessary in order to clarify the exact role of angiogenic growth factor in the pathophysiology of arterial stiffness.
